Your browser doesn't support javascript.
loading
Preparing for patients with high-consequence infectious diseases: Example of a high-level isolation unit.
Pfäfflin, Frieder; Stegemann, Miriam Songa; Heim, Katrin Moira; Achterberg, Stephan; Pfitzner, Ursula; Götze, Louise; Oesterhelweg, Lars; Suttorp, Norbert; Herzog, Christian; Stadtmann, Benjamin; Uhrig, Alexander.
Afiliación
  • Pfäfflin F; Department for Infectious Diseases and Respiratory Medicine, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.
  • Stegemann MS; Department for Infectious Diseases and Respiratory Medicine, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.
  • Heim KM; Department for Infectious Diseases and Respiratory Medicine, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.
  • Achterberg S; Department for Infectious Diseases and Respiratory Medicine, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.
  • Pfitzner U; Department for Infectious Diseases and Respiratory Medicine, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.
  • Götze L; Department for Infectious Diseases and Respiratory Medicine, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.
  • Oesterhelweg L; Institute of Legal Medicine and Forensic Sciences, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.
  • Suttorp N; Department for Infectious Diseases and Respiratory Medicine, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.
  • Herzog C; Centre for Biological Threats, Strategy and Incident Response, Robert Koch-Institute, Berlin, Germany.
  • Stadtmann B; Department for Infectious Diseases and Respiratory Medicine, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.
  • Uhrig A; Department for Infectious Diseases and Respiratory Medicine, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.
PLoS One ; 17(3): e0264644, 2022.
Article en En | MEDLINE | ID: mdl-35239726
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Aislamiento de Pacientes / Enfermedades Transmisibles / Cuidados Críticos / Unidades de Cuidados Intensivos Tipo de estudio: Prognostic_studies Límite: Humans País/Región como asunto: Europa Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Aislamiento de Pacientes / Enfermedades Transmisibles / Cuidados Críticos / Unidades de Cuidados Intensivos Tipo de estudio: Prognostic_studies Límite: Humans País/Región como asunto: Europa Idioma: En Año: 2022 Tipo del documento: Article